Patterns of anti-CGRP mAbs use and triptan consumption before and after anti-CGRP treatment initiation: a descriptive drug utilization study in Tuscany region, ItalyFirst published 15/02/2022 Last updated 29/07/2022 EU PAS number: EUPAS45727StudyOngoing